By Tilly Metz, MEP
Think about the last time you worried about your health. You probably didn't think about pesticide regulation, food labelling rules or air quality standards. You should have. These decisions can shape your cancer risk more than anything your doctor tells you at your next check-up.
When Europe launched its Beating Cancer Plan, it pitched prevention modestly, as the 'most cost-effective investment' a health system can make. That framing is now out of date: prevention has outgrown an accountant's logic. It has become the proving ground for how Europe handles chronic disease, health inequality and industrial policy, all at once.
Why? Cancer does not begin in a hospital. It begins in a field sprayed with pesticides, a factory using a hazardous solvent, a supermarket aisle stacked with ultra-processed food, a city choking on polluted air. The decisions that actually determine who gets cancer are made by agriculture ministries, chemical safety agencies, tax authorities and consumer-protection agencies. None of these institutions would describe itself as part of the health system. But all of them function as one, and Europe's next task is to make them act like one.
That task gets easier once you notice something inconvenient about the way health policy is usually organised: cancer is treated as a special case, when it isn't one. Cardiovascular disease, diabetes and respiratory illness are driven by the same short list of causes – tobacco, alcohol, poor diets, pollution, hazardous exposure at work, and the commercial pressures that push all of the above onto supermarket shelves and billboards. A person lighting a cigarette is not thinking 'cancer risk' today and 'heart disease risk' tomorrow. It is one health risk, to one body, from one bad decision. Splitting cancer strategy from cardiovascular strategy from respiratory strategy suits filing systems, not human biology. That split should end.
The Safe Heart Plan proves this point. The European Parliament's health committee (SANT) recently approved a report on cardiovascular disease that borrows its model directly from Europe's Beating Cancer Plan: measurable targets, binding cooperation between Member States, a real implementation timeline, and a clear acknowledgement that prevention happens mostly outside hospitals. If this model works as well for hearts as it has for cancer, disease-specific silos start to look like the obstacles they are.
Push the logic one step further and you reach 'One Health' – the idea that human health, animal health and environmental health rise or fall together. Antimicrobial resistance, chemical exposure, environmental degradation and climate change are not marginal concerns confined to environmental policy while health systems attend to medicine. They are upstream causes of cancer, acting on the same population, through the same mechanisms. A prevention strategy that stops at the hospital door is not a strategy. It is an admission of defeat before the fight begins.
Cancer prevention has already shown what happens when ambitious legislation, hard evidence and public health strategy pull in the same direction: lives saved. The question is no longer whether that formula works. It is whether Europe has the nerve to apply it beyond cancer, to the wider range of non-communicable diseases that quietly cause more harm across Europe than almost anything else.
If Europe's next generation of health strategy builds on this foundation, the Beating Cancer Plan will not be remembered simply as a cancer policy that succeeded. It will be remembered as the moment Europe started making disease prevention a shared responsibility for all.